Cell Source, Inc. Deferred Federal Income Tax Expense (Benefit)
Cell Source, Inc. (CLCS) reported Deferred Federal Income Tax Expense (Benefit) of -$787.50 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-04-07
- Cell Source, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$787.50K.
- Cell Source, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$853.96K.
- Cell Source, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$669.70K.
- Cell Source, Inc. deferred federal income tax expense (benefit) for fiscal 2021 was -$994.75K.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$787.50K 10-K · filed 2026-04-07 | |
| 2023-12-31 | -$853.96K 10-K · filed 2026-04-07 | |
| 2022-12-31 | -$669.70K 10-K · filed 2024-06-24 | |
| 2021-12-31 | -$994.75K 10-K · filed 2023-08-08 | |
| 2020-12-31 | -$883.03K 10-K · filed 2022-04-15 | -$111.73K 10-K · filed 2021-04-15 |
| 2019-12-31 | -$105.99K 10-K · filed 2021-04-15 | |
| 2018-12-31 | -$226.00K 10-K · filed 2020-03-30 | -$403.59K 10-K · filed 2019-04-01 |
| 2017-12-31 | $110.00K 10-K · filed 2019-04-01 | |
| 2016-12-31 | -$623.00K 10-K · filed 2018-07-25 | |
| 2015-12-31 | -$226.00K 10-K · filed 2018-07-25 | |
| 2014-12-31 | -$82.00K 10-K · filed 2016-04-14 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-13 |